Moderna
MRNA
$132.68
Share price
2.80%
Change (1 day)
1.86%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Total assets
Total assets on the balance sheet as of March 2024 : $16.72 B
According to Moderna 's latest financial reports the company's total assets are $16.72 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Moderna - Total assets on balance sheet (from 2017 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $18.42 B | -28.74% |
| 2022-12-31 | $25.85 B | 4.82% |
| 2021-12-31 | $24.66 B | 236.23% |
| 2020-12-31 | $7.33 B | 361.61% |
| 2019-12-31 | $1.58 B | -19% |
| 2018-12-31 | $1.96 B | 80.93% |
| 2017-12-31 | $1.08 B | -23.47% |
| 2016-12-31 | $1.41 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 927.95% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 463.90% | 🇨🇭 Switzerland |
 Merck MRK | $106.67 B | 537.67% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $30.75 M | -99.82% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Athersys ATHX | $7.42 M | -99.96% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.82 B | -77.14% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.62 B | -96.26% | 🇺🇸 USA |